ICU Medical (ICUI) Tops Q4 EPS by 31c, Offers Guidance

ICU Medical (NASDAQ: ICUI) reported Q4 EPS of $1.94, $0.31 better than the analyst estimate of $1.63. Revenue for the quarter came in at $315.5 million versus the consensus estimate of $295.7 million.

GUIDANCE:

ICU Medical sees FY2020 EPS of $6.50-$7.20, versus the consensus of $7.21.

For the Fiscal Year 2020, the Company expects adjusted EBITDA to be in the range of $240 million to $260 million, and adjusted diluted EPS to be in the range of $6.50 to $7.20.

For earnings history and earnings-related data on ICU Medical (ICUI) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Hermès can regain momentum despite China weakness, Jefferies says
• Stifel Reiterates Buy Rating on FedEx (FDX) Ahead of Q4 Earnings